Price $7.74 |
Market Cap
9.87B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.11
|
P/S
0.66
|
Dividend %
-
|
|
P/CF
20.4
|
P/FCF
17.6
|
Op. Cash Flow
1.15M
|
FCF
0.5
|
|
Op. Margin
3.70%
|
Net Margin
-4.00%
|
ROE
-6.10%
|
ROI
4.50%
|
|
ROA
-1.30%
|
EPS Growth
84.70%
|
Current Ratio
1.1
|
Debt/Equity
210.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Repro-Med Systems, Inc. (KRMD) | $2.43 | - | - | 98.3M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $2.96 | - | - | 76.7M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.91 | - | - | 61.3M | Strong Buy |
| Arbutus Biopharma Corp (ABUS) | $2.84 | - | - | 361.4M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.29 | - | - | 63.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
